Brief: IBio To Provide An Update On Cardiopulmonary Program Targeting Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction (Ph-Hfpef)
16/03/2026 21:21
March 16 (Reuters) - iBio Inc IBIO.O: IBIO TO PROVIDE AN UPDATE ON CARDIOPULMONARY PROGRAM TARGETING PULMONARY HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFPEF) IBIO INC - EXPECTS TO DECLARE BISPECIFIC ANTIBODY CANDIDATE FOR PH-HFPEF IN Q3 2026 Source text: ID:nGNXY88gB Further company coverage: IBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on iBio
See all newsBrief: iBio - IBIO-610 Plus Semaglutide Preserves Lean Mass In Eight-Week Obese NHP Study
Brief: Ibio Reports Fiscal Year 2026 Financial Results And Provides Corporate Update
Brief: Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron